Malignant Pleural Effusion (MPE)
Implantation of permanent pleural catheter for palliation of malignant pleural effusion
5
The Concentration of Interleukin-27 in the pleural fluid of patients with exudative pleural effusion and its diagnostic value in differentiating between benign and malignant pleural effusion
5
Discriminating Tuberculous Pleural Effusion from Malignant Pleural Effusion Based on Routine Pleural Fluid Biomarkers, Using Mathematical Methods
9
Management of malignant pleural effusion: challenges and solutions
13
Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion
7
Comparative Analysis of Mean Pleural Fluid D-dimer Level in Malignant and Non-Malignant Pleural Effusion Patients
5
The diagnostic significance and the assessment of the value of vascular endothelial growth factor as a marker for success of chemical pleurodesis in malignant pleural effusion
5
Liquid Based Cytologyand Cell Block in Malignant Pleural Effusion – a Comparative Study
11
Effect of Betadine in chemical pleurodesis in patients with recurrent malignant pleural effusion between 2013 and 2015
6
The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected
10
Liquid Based Cytology and Cell Block in Malignant Pleural Effusion a Comparative Study
11
Comparative study between indwelling pleural drain and intercostal drainage followed by pleurodesis in management of malignant pleural effusion
5
Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer
7
Simple intrapleural hyperthermia at thoracoscopic exploration to treat malignant pleural effusion
6
Diagnostic value of medical thoracoscopy in malignant pleural effusion
5
Mast cells mediate malignant pleural effusion formation
19
Pleural IFN γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion
8
Important prognostic factors for survival in patients with malignant pleural effusion
7
Malignant pleural effusion: from bench to bedside
10
Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer
6